INVENT endorsed PEITHO III study (A half dose of thrombolytic treatment for patients with intermediate high risk of pulmonary embolism) is looking for potential sites and investigators. The design of the PEITHO III study will be presented by the principal investigator Dr. Stavros Konstantinides at the upcoming Annual Conference of Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, in Toronto, Canada. Click here to learn more about the study and how to participate!
